ISSN: 2155-9880
+44 1300 500008
Shuantong Lin1*, Juan Lu2, Jianyue Wang3
Congenital Heart Disease (CHD) accounts for nearly one-third of all congenital birth defects and affects approximately 1 in 100 births each year in the United States [1]. A meta-analysis of 260 studies incorporating global data concluded that the prevalence of CHD continued to rise [2]. Nonindustrialized countries exhibited unfavorable or worsening risks for recent time periods and birth cohorts [3]. While 95% of children with simple CHD and 75% to 90% of children with complex CHD can survive into adulthood, approximately 50% of children with CHD experience neurocognitive deficits and impairments [4,5]. Nonindustrialized countries face challenges in the prevention and treatment of CHD [3].
Published Date: 2024-12-30; Received Date: 2024-11-28